Crossmark

Association of uPA and PAI-1 tumor levels and 4G/5G variants of PAI-1 gene with disease outcome in luminal HER2-negative node-negative breast cancer patients treated with adjuvant endocrine therapy

Crossref DOI link: https://doi.org/10.1186/s12885-018-5255-z

Published Online: 2019-01-15

Published Print: 2019-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Jevrić, Marko

Matić, Ivana Z.

Krivokuća, Ana

Đorđić Crnogorac, Marija

Besu, Irina

Damjanović, Ana

Branković-Magić, Mirjana

Milovanović, Zorka

Gavrilović, Dušica

Susnjar, Snezana

Kisić Tepavčević, Darija

Stanojković, Tatjana
Funding

Funding for this research was provided by:

Ministarstvo Prosvete, Nauke i Tehnološkog Razvoja (175011, III41026)
License Information

Text and Data Mining valid from 2019-01-15
More Information

Article History

Received: 1 November 2017

Accepted: 27 December 2018

First Online: 15 January 2019

Ethics approval and consent to participate

: The investigations on breast cancer specimens deposited in the institutional tumor bank was approved by the Ethics Committee of the Institute of Oncology and Radiology of Serbia. The informed consent was obtained from each patient.

: Not applicable.

: The authors declare that they have no competing interests.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Document is current

Any future updates will be listed below